JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: Results from a Phase 2 randomized controlled clinical trial

Katherine R. Tuttle, Frank C. Brosius, Sharon G. Adler, Matthias Kretzler, Ravindra L. Mehta, James A. Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria E. Silk, Tracy E. Cardillo, Kevin L. Duffin, Joseph V. Haas, William L. Macias, Fabio P. Nunes, Jonathan M. Janes

Research output: Contribution to journalArticlepeer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: Results from a Phase 2 randomized controlled clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences